Still, in mice, miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting Fbxl19, revealing a novel pathway in adipose tissue formation and a new potential therapeutic target for obesity [64]. This evidence concerns the gene FBXL19 and obesity disorder.